DRUG RETENTION OF BIOLOGIC AND TARGETED SYNTHETIC DMARDS IN KOREAN SEROPOSITIVE RHEUMATOID ARTHRITIS (RA) PATIENTS: A REALWORLD SINGLE-CENTER RETROSPECTIVE STUDY

被引：0
|
作者：
Lee, B. W. [1 ]
Lee, J. J. [1 ]
Kim, W. U. [1 ]
机构：
[1] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Rheumatol,Dept Internal Med, Seoul, South Korea
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Rheumatoid arthritis; Targeted synthetic drugs; bDMARD;
D O I：
10.1136/annrheumdis-2023-eular.3677
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0854
引用
收藏
页码：730 / 731
页数：2
相关论文
共 50 条
  • [21] Efficacy of tofacitinib on rheumatoid arthritis: A retrospective single-center cohort study
    Qi, Yuhui
    Yu, Juan
    ASIAN JOURNAL OF SURGERY, 2023, 46 (09) : 3961 - 3962
  • [22] DRUG PERSISTENCE ON JANUS KINASE (JAK) INHIBITORS COMPARED TO BIOLOGIC DMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS: RETROSPECTIVE STUDY IN THE AUSTRALIAN POPULATION
    Scheepers, Lieke
    Jones, Graeme
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 21 - 21
  • [23] DRUG PERSISTENCE ON JANUS KINASE (JAK) INHIBITORS COMPARED TO BIOLOGIC DMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS: RETROSPECTIVE STUDY IN THE AUSTRALIAN POPULATION
    Scheepers, L.
    Jones, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1335 - 1335
  • [24] DRUG COST FOR BIOLOGIC AND TARGETED SYNTHETIC DMARDS FOR RHEUMATOID ARTHRITIS PATIENTS IN NORWAY FROM 2010 TO 2019-A COUNTRY WITH A NATIONAL TENDER SYSTEM FOR DRUG PRESCRIPTION
    Brkic, A.
    Diamantopoulos, A.
    Haugeberg, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 145 - 146
  • [25] THE RETENTION RATE OF ABATACEPT IN VERY ELDERLY PATIENTS (75 YEARS AND ABOVE) WITH RHEUMATOID ARTHRITIS, SINGLE-CENTER, RETROSPECTIVE, OBSERVATIONAL STUDY
    Kikuchi, E.
    Uekubo, K.
    Aoki, N.
    Yoshioka, T.
    Okai, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 724 - 724
  • [26] A Canadian Retrospective Chart Review Evaluating Concomitant Methotrexate De-escalation Patterns in Patients with Rheumatoid Arthritis Treated with Biologic or Targeted Synthetic DMARDs
    Bessette, Louis
    Florica, Brandusa
    Naik, Latha
    Sholter, Dalton
    Fournier, Pierre-Andre
    Girard, Tanya
    Liazoghli, Dalinda
    Baer, Philip A.
    RHEUMATOLOGY AND THERAPY, 2024, 11 (05) : 1165 - 1180
  • [27] Comments on "Single-center cohort analyzed the efficacy of tofacitinib on rheumatoid arthritis patients: A retrospective study"
    Tang, Mei
    Wang, Gang
    Liu, Zhichun
    ASIAN JOURNAL OF SURGERY, 2023, 46 (11) : 5075 - 5075
  • [28] Risk Factors Analysis for the Development of Hypocomplementemia in Rheumatoid Arthritis Patients: A Single-Center Retrospective Study
    Chen, Yinyi
    Xiao, Chunlan
    Liao, Yubin
    Tan, Liming
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 3583 - 3592
  • [29] PREVALENCE AND ASSOCIATED FACTORS OF ATLANTOAXIAL SUBLUXATION IN PATIENTS WITH RHEUMATOID ARTHRITIS: A SINGLE-CENTER RETROSPECTIVE STUDY
    Song, Y. J.
    Kim, S. Y.
    Lim, C.
    Kim, H. W.
    Nam, E.
    Cho, S. K.
    Sung, Y. K.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 2054 - 2055
  • [30] Do the drug doses of conventional synthetic DMARDs used for the treatment of biologic/targeted-synthetic DMARDs naive rheumatoid arthritis patients affect QuantiFERON-TB Gold Plus test results?
    Zehra Ozsoy
    Adem Ozdemir
    Mustafa Ekici
    Emre Bilgin
    Levent Kılıc
    Sedat Kiraz
    Zeynep Sarıbas
    Burçin Sener
    Omer Karadag
    Rheumatology International, 2023, 43 : 1445 - 1451
12345